Drug
quizartinib
Marketed as VANFLYTA.
Generic name
quizartinib
Brand names
VANFLYTA
First FDA approval
2023-07-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA216993 | VANFLYTA | 2023-07-20 | DAIICHI SANKYO INC |
Manufacturers
DAIICHI SANKYO INC
Frequently asked questions
When was quizartinib FDA approved?
Earliest FDA approval on record: 2023-07-20.
What brand names are sold as quizartinib?
VANFLYTA.
Sources
Appeal a quizartinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com